Hideki Igata - Concepedia

Author

Hideki Igata

Takeda (Japan)

Also Known As

H Igata, Hideki IGATA, Hideki Igata

Publications

638

Citations

H-Index

Concepts

All Affiliations

Takeda (Japan)Kyoto University

About

Hideki Igata is an author at Takeda (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	267
2	Natural Sciences	2	2	118
3	Biochemistry	2	2	118
4	Allergy	1	1	96
5	Cellular Physiology	1	1	96

Hideki Igata

Publications

613

Citations

H-Index

Page 1

	Year	Citations
In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies Mami Ojima, Hideki Igata, Masayuki Tanaka, Journal of Pharmacology and Experimental Therapeutics	2010	146
Modulation of Cytokine Production and Protection Against Lethal Endotoxemia by the Cardiac Glycoside Ouabain Akira Matsumori, Koh Ono, Ryosuke Nishio, Circulation Heart FailureTyrosine KinaseImmunologyImmune RegulationCell Death	1997	96
Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Ono K, Akira Matsumori, Yoichi Furukawa, PubMed	1999	92
Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2) Yasutomi Asano, Shuji Kitamura, Taiichi Ohra, Bioorganic & Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryBiochemistrySelective Jnk InhibitorsMedicine	2008	90
High Doses of Digitalis Increase the Myocardial Production of Proinflammatory Cytokines and Worsen Myocardial Injury in Viral Myocarditis Akira Matsumori, Hideki Igata, Koh Ono, Japanese Circulation Journal	1999	83
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models Keiji Kusumoto, Hideki Igata, Mami Ojima, European Journal of Pharmacology HypertensionMedicineAntihypertensive TherapyPhysiologyDiabetes	2011	53
Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1) Yasutomi Asano, Shuji Kitamura, Taiichi Ohra, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistrySelective Jnk InhibitorsMedicineNatural Sciences	2008	28
<i>In vitro</i> and <i>in vivo</i> pharmacology of a structurally novel Na<sup>+</sup>‐H<sup>+</sup> exchange inhibitor, T‐162559 Keiji Kusumoto, Hideki Igata, Akemi Abe, British Journal of Pharmacology	2002	25

Page 1